Scanning electron microscopy images of biofilm architecture seen on the mucosal surface of an adenoid removed from a patient with chronic rhinosinusitis. A, Low-power magnification (original magnification ×500). B, Individual cocci and rods are seen at high-power magnification (original magnification ×2000).
Scanning electron microscopy images of a barren adenoid surface of a sample removed from a patient with obstructive sleep apnea. A, Low-power magnification (original magnification ×500). B, Note the absence of bacterial morphological forms at high-power magnification (original magnification ×2000).
Algorithm demonstrating a proposed paradigm in the pathogenesis of pediatric chronic rhinosinusitis (CRS). GERD indicates gastroesophageal reflux disease; NP, nasopharyngeal; OMC, osteomeatal complex; and URI, upper respiratory tract infection.
Coticchia J, Zuliani G, Coleman C, Carron M, Gurrola J, Haupert M, Berk R. Biofilm Surface Area in the Pediatric NasopharynxChronic Rhinosinusitis vs Obstructive Sleep Apnea. Arch Otolaryngol Head Neck Surg. 2007;133(2):110-114. doi:10.1001/archotol.133.2.110
Copyright 2007 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2007
To compare the percentage of mucosal surface area of adenoids infected with biofilms removed from children with chronic rhinosinusitis (CRS) vs children with obstructive sleep apnea (OSA).
Comparative microanatomical investigation of adenoid mucosa from patients with CRS and OSA using scanning electron microscopy.
University-affiliated hospitals and ambulatory surgery center.
Four girls and 12 boys ranging in age from 3 months to 10 years.
Main Outcome Measure
Measurements of biofilm coverage of the entire adenoidal surface.
Adenoids removed from patients with CRS had dense mature biofilms covering the mucosal surface; they had a mean of 94.9% of their mucosal surface covered with mature biofilms, compared with a mean of 1.9% coverage on the adenoids removed from patients with OSA. This difference was statistically significant at P<.001.
Adenoids removed from patients with CRS had almost their entire mucosal surface covered with biofilms vs scant coverage for patients with OSA. Biofilms in the nasopharynx of children with CRS may act as a chronic reservoir for bacterial pathogens resistant to standard antibiotics. The mechanical debridement of the nasopharyngeal biofilms may explain the observed clinical benefit associated with adenoidectomy in this subset of pediatric patients.
Chronic rhinosinusitis (CRS) in the pediatric population is a complex disease with a considerable effect on the US economy. The health care expenditure in the United States in 1996 for rhinosinusitis in the pediatric population was estimated to be $1.8 billion.1 Most otolaryngologists agree that the cornerstone of treating CRS is a prolonged course of a broad-spectrum β-lactamase stable oral antibiotic in an attempt to cover the varied pathogens that may be present in the sinuses. These are not the same well-defined set of organisms that may exist in acute sinusitis. Anaerobes are cultured from the paranasal sinuses of children diagnosed as having CRS at rates ranging from 2% to 100%.2
Alternatives to the standard course of oral antibiotic therapy include adenoidectomy, functional endoscopic sinus surgery, and long-term intravenous antibiotic therapy. Adappa and Coticchia3 achieved a 91% long-term success rate in treating 22 patients with CRS during a mean of 5 weeks of intravenous antibiotic therapy with concurrent adenoidectomy. Recent findings suggest that adenoidectomy by itself may provide benefits for patients with CRS. In a study by Vandenberg and Heatley,4 58% of children demonstrated near or complete symptom resolution of CRS after adenoidectomy. These authors suggest that adenoidectomy improves sinonasal symptoms by eliminating airway obstruction and secretion stasis, as well as by removing a nidus for chronic bacterial infection.
Biofilms are increasingly associated with chronic infectious processes. Using a simple light microscope, Antonie van Leeuwenhoek (1632-1723) was the first to describe the concept of microorganisms bound to a surface in the form of dental plaque.5 In the 1970s, there was a reemergence of the notion of the bacterial biofilm when Characklis6 studied microbial slime in industrial water systems and noted its resistance to disinfectants. A transition in thinking has begun in that bacteria are no longer thought to exist singularly as mere planktonic organisms but rather as well-organized ecosystems even within a human host. These complex ecosystems are well suited for conditions of environmental stress such as crowding and altered oxygen tension. It is believed that, at any given time, 99% of bacteria exist in the form of a hydrated matrix of polysaccharides and protein slime known as a biofilm.7 According to a recent public announcement from the National Institutes of Health, more than 60% of human bacterial infections involve biofilms.8 Different nosocomial infections related to the use of urinary catheters, orthopedic devices, prosthetic heart valves, and central venous catheters are associated with the adherence of biofilms to a surface.9 Infectious processes attributed to bacterial biofilms are increasingly difficult to treat secondary to resistance to antimicrobial therapy, and in the case of artificial heart valves and indwelling catheters, removal is the only means of eradication.
Biofilms are difficult to eradicate, and their formation on adenoid surfaces provides a mechanism for persistent infection seen in CRS.10 Biofilms form when individual planktonic bacteria coalesce and adhere to various surfaces via glycoconjugate moieties.11 The life cycle of biofilms can be divided into 3 parts, namely, attachment, growth, and detachment.12 During the attachment phase, the substrate must be adequate to be adsorbed for the bacteria to irreversibly attach to the surface. As the cells divide, an exopolysaccharide matrix is formed. The biofilm then begins to form towers and water channels through the matrix. These channels aid in the elimination of waste and contribute to a pH gradient within the matrix. Finally, the individual bacteria begin to shed from the biofilm to colonize another surface. The oxygen tension gradient present in the biofilm allows for increased metabolic activity in superficial layers of the matrix while the underlying layers persist in a quiescent phase. Chemical signaling, known as quorum sensing, allows for cell-cell communication within the biofilm. Antibiotics may temporarily reverse symptoms caused by shedding of planktonic bacteria; however, unless the colonized surface is also removed, the infection will recur.13
To demonstrate a new paradigm in the pathogenesis of CRS, our laboratory set out to quantitatively describe the anatomical microstructure of adenoids removed from children with CRS vs children with obstructive sleep apnea (OSA). Because microscopy is the only technique whereby bacterial biofilms can be studied at the single-cell level, scanning electron microscopy (SEM) was used to detect and help quantify biofilm architecture.14 Despite the use of standard measures in attempting to eradicate CRS from our pediatric population, we encounter many treatment failures. Therefore, we contend that biofilm formation might play an important role in the pathogenesis of this disease.
Institutional review board approval for the study was obtained from Wayne State University, Detroit, Mich. All samples were obtained from adenoidectomies performed by us for CRS and OSA at Children's Hospital of Michigan (Detroit), St Joseph Mercy Hospital (Pontiac, Mich), and Lahser Ambulatory Surgery Center (Southfield, Mich). In some patients with OSA, the adenoids and tonsils were removed. The ages of the patients ranged from 3 months to 10 years. Sixteen samples were collected from 4 girls and 12 boys. Chronic rhinosinusitis was defined and documented in the medical record as an infectious process of the paranasal sinuses lasting longer than 3 months. All patients diagnosed as having CRS had failed a prolonged course of oral antibiotics lasting at least 4 weeks.
All samples were prepared for SEM using the following techniques. Tissue was initially fixed for 1 hour in 2.5% glutaraldehyde in 0.1M Sorensen phosphate buffer (pH 7.4). Two rinses of 10 minutes each were then carried out using 0.1M Sorensen phosphate buffer. Next, the samples were treated with 1% osmium tetroxide for 1 hour. After this, the tissue was dehydrated with successively greater concentrations of ethanol as follows: 30% for 15 minutes, 50% for 15 minutes, 70% for 15 minutes, 90% for 15 minutes, and 100% for 15 minutes (this last dehydration step was repeated). Finally, the tissue was washed with hexamethyldisilavane (Electron Microscopy Sciences, Hatfield, Pa) 4 times for 15 minutes. A few drops of hexamethyldisilavane were then placed on the samples, and they were left to dry overnight in a hood. Samples were then mounted and gold sputter coated in final preparation for imaging.
Imaging was done at our SEM laboratory using a microscope (JSM-6400; JEOL Ltd, Tokyo, Japan) (R.B. was present at all imaging sessions). Biofilm architecture consistent with the extant literature was easily distinguishable from the barren surface of regions devoid of biofilms.15,16
The SEM images were analyzed using Carnoy version 2.0 software (http://www.kuleuven.ac.be/bio/sys/carnoy). The software was used to obtain measurements of biofilm coverage of the entire adenoidal surface.
Figure 1 shows and low-power and high-power SEM images of adenoid tissue removed from a patient with documented CRS. In contrast, Figure 2 shows low-power and high-power SEM micrographs of an adenoid surface devoid of biofilm architecture. This adenoid sample was removed from a patient with documented OSA. Carnoy software quantified the biofilm surface area of each sample imaged using SEM. The Table gives these surface areas and the patient demographics and diagnoses.
Adenoids removed from patients with CRS had a mean of 94.9% of their mucosal surface covered with mature biofilms, compared with a mean of 1.9% coverage on the adenoids removed from patients with OSA. This difference was statistically significant at P<.001. Statistics were obtained using nonparametric Mann-Whitney comparisons between the 2 experimental groups.
Pediatric CRS is a disease that is resistant to standard antimicrobial therapy. However, adenoidectomy has been shown to have some efficacy in ameliorating the symptoms of CRS. Possible theories for its success include relieving a source of nasopharyngeal obstruction and removing a nidus for chronic bacterial infection. In studies17,18 of otitis media, the benefit of adenoidectomy seems to be unrelated to the size of the adenoid. Hence, the more likely explanation for the effectiveness of adenoidectomy in treating CRS is the elimination of a nasopharyngeal source for reinfection of paranasal sinus mucosa.
Ramadan et al12 first provided direct evidence of biofilm formation in paranasal sinus mucosa of patients with CRS. Tissue samples were removed from the ethmoid bulla of 5 adult patients undergoing functional endoscopic sinus surgery and were imaged using SEM. All 5 patients showed evidence of biofilms resembling those of Staphylococcus species. No control subjects were included in this study.
The demonstration of resistant biofilm infections in the nasopharynx and paranasal sinuses of children with CRS allows us to explain some well-documented clinical observations previously not understood. In classic teaching, it was believed that the pathogenic bacteria seen in CRS needed to adhere to the nasopharynx, enter the sinus ostia, and then replicate to establish infection. We propose another sequence of events given the recent evidence of biofilms in the nasopharynx and paranasal sinuses. We suspect that the first step in this process is entry of a known sinusitis pathogen into the nasopharynx. Colonization and establishment of the biofilm microenvironment follow. Once established, the biofilm is able to shed planktonic organisms. Therefore, a cycle of reentry and reinfection of nasopharyngeal pathogens into the sinuses creates the clinical entity known as CRS. Figure 3 shows this paradigm.
Using the biofilm model, we may gain new insight into the pathogenesis and potential beneficial treatments for pediatric CRS. The first step in this process would be inflammation of the nasopharynx. This could be caused by nasal allergy, gastroesophageal reflux disease, or viral upper respiratory tract infection. Colonization with known rhinosinusitis pathogens (Moraxella catarrhalis, Haemophilus influenzae, Streptococcus pneumoniae, or Staphylococcus aureus) would follow. The next step would be establishment of the nasopharyngeal biofilm. This nasopharyngeal biofilm could intermittently shed metabolically active rhinosinusitis pathogens. If there was inflammation of the osteomeatal complex and altered ciliary function, pathogens could gain entry into the maxillary sinus. Once there, a new biofilm could be established. The clinical symptoms of such a biofilm infection often lead to a short course of prescribed oral antibiotic therapy. Although these antibiotics may cause some temporary clinical improvement, the nasopharyngeal and maxillary sinus biofilm would remain resistant. Imaging, usually a computed tomographic scan, may be ordered after several rounds of antibiotic therapy, demonstrating persistent disease or chronic infection.
Several medical options exist for treating pediatric CRS. These include saline rinses, nasal steroids, and a prolonged course of oral or parental antibiotics. In a substantial number of patients, the recalcitrant nature of CRS proves these therapeutic measures to be insufficient for complete disease eradication. When maximum medical therapy fails, the treating physician must consider other options.
There are 3 main surgical options in the treatment of CRS. These include (1) adenoidectomy, sinus aspiration or lavage, and parenteral antibiotics; (2) adenoidectomy, sinus aspiration or lavage, and prolonged oral therapy; and (3) adenoidectomy and limited functional endoscopic sinus surgery. Option 1 would débride the nasopharyngeal and mucociliary biofilm and alter the oxygen tension within the maxillary sinus while the intravenous antibiotics would target metabolically active organisms. Option 2 would also débride the nasopharyngeal and mucociliary biofilm and target metabolically active pathogens. Option 3 would débride the nasopharyngeal and paranasal sinus biofilm and increase oxygen tension within the sinus, allowing for reestablishment of normal sinus anatomy and physiology.
Although SEM has been used by investigators to identify and characterize biofilms, there are some drawbacks in using this method. The use of electron microscopy requires complex sample preparation, including biofilm dehydration and fixation. The sample preparation may result in biofilm shrinkage, damage, and (eventually) biofilm loss.19 However, our results show such a large statistical difference in biofilm coverage between the 2 experimental groups that error in processing is expected to be negligible.
Newer techniques, such as confocal laser scanning microscopy with or without fluorescent in situ hybridization, have the advantage of visualizing 3-dimensional structures of fully hydrated specimens noninvasively, in situ and in vivo, in a time-resolved manner.19 These methods allow for further elucidation of the structure-function relationships in biofilms. Our laboratory is applying these methods to our investigation of middle ear biofilms, and we plan to expand these techniques to our investigation of pediatric CRS. Despite many methods used, we were unable to find any studies in the literature comparing the sensitivity and specificity of the spectroscopic techniques used to detect human host biofilms.
In addition to the aforementioned projects, our laboratory is expanding our data set in both of the experimental groups described herein. Computed tomographic scans are being obtained in patients diagnosed as having CRS. Such information would strengthen our clinical diagnosis of CRS over other infectious or inflammatory disorders such as adenoiditis. We are also culturing and performing polymerase chain reaction on sinus aspirates and adenoid tissue. Based on our hypothesis, we would expect to find the same set of pathogens in both anatomical locations.
To our knowledge, our study is the first to identify biofilm architecture on the surface of adenoids in direct association pediatric CRS. This is a crucial first step in supporting the notion of the role of adenoidectomy in mechanical debridement of potential pathogens that reinfect the paranasal sinuses. Although our sample is small, the differences found on SEM examination are notable.
The difficulty in treating pediatric CRS has long been established. Repeated courses of oral and parenteral antibiotic therapy provide short-term improvement in alleviating the symptoms of CRS. Many physicians and patients have been discouraged to see the same infectious processes recur several times a year. The presence of biofilms in the pediatric nasopharynx may explain why so many apparently successful interventions ultimately fail. We propose a new paradigm in the pathogenesis of CRS that may explain the benefit seen with mechanical debridement of adenoid tissue in the pediatric nasopharynx.
Correspondence: James Coticchia, MD, Department of Otolaryngology, Wayne State University, Suite 5E-University Health Center, 4201 St Antoine, Detroit, MI 48201 (email@example.com).
Submitted for Publication: May 4, 2006; final revision received August 22, 2006; accepted September 6, 2006.
Author Contributions: Drs Coticchia, Zuliani, Carron, Haupert, and Berk, Ms Coleman, and Mr Gurrola had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Coticchia, Zuliani, and Berk. Acquisition of data: Coticchia and Haupert. Analysis and interpretation of data: Coleman, Gurrola, Zuliani, and Carron. Drafting of the manuscript: Zuliani. Critical revision of the manuscript for important intellectual content: Coticchia, Coleman, Carron, Gurrola, Haupert, and Berk. Obtained funding: Coticchia. Administrative, technical, and material support: Gurrola and Berk. Study supervision: Coticchia, Carron, and Berk.
Financial Disclosure: None reported.
Previous Presentation: This study won the Charles F. Ferguson Clinical Research Award at the 21st Annual Meeting of the American Society of Pediatric Otolaryngology; May 22, 2006; Chicago Ill.